Martínez-Medel J, Martínez-Rubio MP, Cabistany-Esqué AC, Yanguas-Barea N, Aísa-Rivera G, Royo-Arilla B, Monzón-Muñoz FJ

Language: Spanish
References: 18
Page: 247-252
PDF size: 453.68 Kb.

ABSTRACT

Fallopian tube cancer is the less frequent gynecological cancer. It occurs typically between 40 and 65 years old. Diagnosis is usually achieved earlier than in ovarian cancer cases, due to early symptoms (typically abdominal pain, hydro-hematorrhea and adnexal mass). Preoperative correct diagnosis is infrequent, being most cases diagnosed during the surgery or in the pathological study. Histologically and clinically is similar to ovarian cancer, being the serous low differentiated the most frequent type. An early suspicion and a correct intervention are essential to obtain correct diagnosis and treatment. Treatment protocols are similar to those of ovarian cancer recommended by the FIGO.

REFERENCES

1. Horng HC, Teng SW, Huang BS, Sun HD, Yen MS, et al. Primary fallopian tube cancer: domestic data and up-todate review. Taiwan J Obstet Gynecol 2014;53(3): 287-92.

2. Pectasides D, Pectasides E, Economopoulos T. Fallopian tuve carcinoma: a review. Oncologist 2006;11:902-12.

3. Jeung IC, Lee YS, Lee HN, Park EK. Primary carcinoma of the fallopian tube: report of two cases with literature review. Cancer Res Treat 2009;41:113-6.

4. Bouthselis JG, Thompson JN. Clinical aspects of primary carcinoma of the fallopian tube: a clinical study of 14 cases. Am J Obstet Gynecol 1971;111:98-101.

5. Hernández MA, Pacheco PR, Estrada HMR, García JE, Polanco GJC. Adenocarcinoma invasor primario de trompa de Falopio concomitante con enfermedad pélvica inflamatoria aguda. Comunicación de un caso y revisión de la literatura. Ginecol Obstet Mex 2008;76(2):118-24.

6. Albalat R, Jiménez J, Márquez F, Lizarralde C. Carcinoma de las trompas de Falopio. Clin Invest Gin Obst 2012;39(2):86- 88.

7. Tone AA, Begley H, Sharma M, Murphy J, Rose B, Brown TJ, et al. Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carries resemble highgrade serous carcinoma. Clin Cancer Res 2008;1:4067-78.

8. Latzko W. Linkseitiges tubenkarzinom rechteitige karzinomatose tubo-ovarial cyste. Zentralbl Gynak 1916;40:599.

9. Ajithkumar TV, Minimole AL, John MM. Primary fallopian tube carcinoma. Obstet Gynecol Surv 2005;60:247-52.

10. Ma FH, Cai SQ, Qiang JW, Zhao SH, Zhang GF, Rao YM. MRI for differentiating primary fallopian tube carcinoma from epithelial ovarian cancer. J Magn Reson Imaging 2014;30:10.[Epub ahead of print]

11. Niloff JM, Klug TL, Schaetzl E. Elevation of serum CA-125 in carcinomas of the fallopian tube, endometrium and endocervix. Am J Obstet Gynecol 1984;148:1057-8.

12. Lukas AH, Alexander CR, Anton HG. The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma. Am Cancer Society 2000;89;7:1555-60.

13. Pectasides D, Pectasides E, Economopoulos T. Fallopian tube carcinoma: a review. Oncologist 2006;11:902-12.

14. Hanton EM, Malkasian GD, Dahlin DC, Pratt JH. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol 1996;94:832-9.

15. Kosary C, Trimble EI. Treatment and survival for women with Fallopian tube carcinoma: a population-based study. Gynecol Oncol 2002;86:190-1.

16. Gaducci A, Landoni F, Sartori E, Maggino T, Zola P, Gabriele A, et al. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study. Gynecol Oncol 2001;81:150-9.

17. Peters WA, Andersen WA, Hopkins MP. Prognosis features of carcinoma of the fallopian tube. Obstet Gynecol 1988;71:757-62.

18. Hu CY, Taymor ML, Hertig AT. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol 1950;59(1):58-67.